Funding Opportunities

NIH Funding Opportunities

Notice to Extend the Expiration Date for PAR-11-205 "Alcohol Education Project Grants (R25)"
Notice NOT-AA-14-005 from the NIH Guide for Grants and Contracts
Mon, 14 Apr 2014 07:58:06 EST

Request for Proposals (RFP) Announcement: "Development of Medical Countermeasures to Mitigate and/or Treat Radiation-Induced Lung Injury after a Radiological/Nuclear Incident BAA-NIAID-DAIT-NIHAI2014001
Notice NOT-AI-14-050 from the NIH Guide for Grants and Contracts
Wed, 16 Apr 2014 02:20:06 EST

Public Pre-application Webinar for PAR-14-067 "Fundamental Mechanisms of Affective Science and Decisional Processes in Cancer Control (U01)"
Notice NOT-CA-14-042 from the NIH Guide for Grants and Contracts
Wed, 16 Apr 2014 03:51:59 EST

Request for Information (RFI): Impact of DSM-5 Changes to Diagnostic Criteria for Autism Spectrum Disorders (ASD) on Research and Services
Notice NOT-HD-14-012 from the NIH Guide for Grants and Contracts
Mon, 14 Apr 2014 08:00:59 EST

NIH Will Open the Research Performance Progress Report (RPPR) for All Type 5 Non-SNAP Progress Reports on April 25, 2014
Notice NOT-OD-14-079 from the NIH Guide for Grants and Contracts
Tue, 15 Apr 2014 01:39:40 EST

Notice of NIH HeLa Genome Sequence Data Submission and Access Policy
Notice NOT-OD-14-080 from the NIH Guide for Grants and Contracts
Wed, 16 Apr 2014 02:51:56 EST

Special Topic Research Education Course: Exploring Auditory and Vestibular biology (R25)
Funding Opportunity RFA-DC-15-001 from the NIH Guide for Grants and Contracts. The NIH Research Education Program (R25) supports research education activities in the mission areas of the NIH.The goal of this NIDCD R25 program is to support educational activities that foster a better understanding of biomedical, behavioral and clinical research and its implications. To this end, this funding opportunity announcement encourages the development of creative educational activities with a primary focus on Courses for Skills Development. Applications are encouraged from research intensive institutions to develop a research skill development course that will expose participants to research tools and methodologies focused on auditory and vestibular research approaches.
Tue, 15 Apr 2014 12:35:18 EST

Evaluation of Iron Species in Healthy Subjects Treated with Generic and Reference Sodium Ferric Gluconate (U01)
Funding Opportunity RFA-FD-14-019 from the NIH Guide for Grants and Contracts. The objective of this study is to conduct in vivo studies to compare plasma total iron (TI), transferrin bound iron (TBI), non-transferrin bound iron (NTBI) levels and oxidative stress after i.v. administration of RLD and generic sodium ferric gluconate injections in healthy subjects. This study is part of post-market surveillance on approved generic products, which can help address potential concerns regarding the quality of generic iron complex products and support the Agencys review standards.
Wed, 16 Apr 2014 02:01:23 EST

Prospective Studies on the Impact of Generic Immunosuppressants on Acute Rejection and Long Term Graft survivals (U01)
Funding Opportunity RFA-FD-14-020 from the NIH Guide for Grants and Contracts. The objective of this study is to conduct prospective clinical studies to investigate the impact of generic immunosuppressants on short term acute rejection and long term patient graft survival. The outcome of this study will help respond to public concerns regarding the interchangeability of generic immunosuppressants and improve review practices of generic immunosuppressants if necessary. The results obtained from this study can be compared to those of retrospective analysis, providing comprehensive perspectives and better research options regarding generic immunosuppressant interchangeability.
Wed, 16 Apr 2014 12:34:11 EST

Retrospective Analysis on the Impact of Generic Immunosuppressants on Acute Rejection and Long Term Graft Survivals (U01)
Funding Opportunity RFA-FD-14-021 from the NIH Guide for Grants and Contracts. The objective of this study is to conduct a retrospective analysis of the impact of generic immunosuppressants on short term acute rejection and long term patient and graft survival since the introduction of generic immunosuppressants. The outcome of this study will help respond to public concerns regarding the interchangeability of generic immunosuppressants and improve review practices of generic immunosuppressants if necessary.
Wed, 16 Apr 2014 11:56:06 EST

The Effect of Different Preparation Methods on the In Vitro and In Vivo Performance of Solid Dispersion Formulations (U01)
Funding Opportunity RFA-FD-14-023 from the NIH Guide for Grants and Contracts. The objective of this study is to investigate the in vitro and in vivo performance for solid dispersion drug products made from different manufacturing processes or polymer carriers, as well as their performance consistency during storage and among batches.The investigation should identify critical process parameters and critical quality attributes for solid dispersion made from different preparation methods and develop discriminating analytical methods.
Wed, 16 Apr 2014 12:10:37 EST

Pharmacokinetic and Pharmacodynamic (PK-PD) Studies of Cardiovascular Drugs (U01)
Funding Opportunity RFA-FD-14-024 from the NIH Guide for Grants and Contracts. The purpose of this project is to conduct a prospective PK/PD study to identify the key product attributes and patient factors that may impact the PK/PD and therapeutic equivalence of metoprolol products. The findings from the PK/PD study will help establish scientific and regulatory standards for assuring therapeutic equivalence of generic metoprolol products.
Wed, 16 Apr 2014 02:10:07 EST

Developing Improved Assessments of Tissue Oxygenation (R43/R44)
Funding Opportunity RFA-HL-15-003 from the NIH Guide for Grants and Contracts. This FOA encourages applications to support the development and/or improvement of devices that can evaluate the dynamic changes in microvascular blood flow and tissue oxygenation in clinical research applications.Devices designed to measure temporal changes in regional perfusion and oxygen delivery following red blood cell transfusion or in peripheral vascular disease are of particular interest.
Tue, 15 Apr 2014 08:57:36 EST

Developing Improved Assessments of Tissue Oxygenation (R41)
Funding Opportunity RFA-HL-15-007 from the NIH Guide for Grants and Contracts. This FOA encourages applications to support the development and/or improvement of devices that can evaluate the dynamic changes in microvascular blood flow and tissue oxygenation in clinical research applications.Devices designed to measure temporal changes in regional perfusion and oxygen delivery following red blood cell transfusion or in peripheral vascular disease are of particular interest.
Tue, 15 Apr 2014 08:59:32 EST

Developing Improved Assessments of Tissue Oxygenation (R44)
Funding Opportunity RFA-HL-15-019 from the NIH Guide for Grants and Contracts. This FOA encourages applications to support the development and/or improvement of devices that can evaluate the dynamic changes in microvascular blood flow and tissue oxygenation in clinical research applications.Devices designed to measure temporal changes in regional perfusion and oxygen delivery following red blood cell transfusion or in peripheral vascular disease are of particular interest.
Tue, 15 Apr 2014 07:57:18 EST